On Tuesday, October 16th Pharmacology Chair Dr. Henrik G. Dohlman announced two of the 2018 Lineberger Award: Irem Dagliyan and Devon Blake. Irem and Devon are both members of the Der Lab at the UNC Lineberger Comprehensive Cancer Research Center. The annual award recognizes outstanding graduate students in the research programs at the Lineberger. Irem … Continue reading 2018 Lineberger Graduate Fellow Award Winners Announced
Slomo and Cindy Silvian Foundation Support Der Lab
In November of 2017, the Der Lab was granted $30,000 from the Slomo and Cindy Silvian Foundation, Inc. to aid graduate student stipend support. This award will support Irem Dagliyan, who is completing her graduate research in the Department of Pharmacology. Irem’s research is focused on the RAF protein kinases, key effectors of KRAS-driven pancreatic cancer … Continue reading Slomo and Cindy Silvian Foundation Support Der Lab
PurpleStride Raleigh-Durham 2018: Running RAScals
UNC's Running RAScals (aka the Der Lab at UNC Lineberger & Friends) participated in this year’s PanCAN #PurpleStride run on Saturday, April 21st. This 5k run raises money to support the Pancreatic Cancer Action Network. The team, organized by Kirsten Bryant, raised $10,839 to support Pancreatic Cancer Research, coming in Fifth in overall fundraising! This was the Der Lab's fifth … Continue reading PurpleStride Raleigh-Durham 2018: Running RAScals
World Pancreatic Cancer Day is November 16
Raising pancreatic cancer awareness can be done as an individual or group all year long, but it is especially important during Pancreatic Cancer Awareness Month in November. During this month, we in the Der Lab are taking time to promote the Pancreatic Cancer Action Network's initiative to Demand Better. For Patients. For Survival. On November 16th, which … Continue reading World Pancreatic Cancer Day is November 16
UNC’s Running RAScals at PurpleStride 5K
The Running RAScals (aka the Der Lab at UNC Lineberger & Friends) participated in this year’s PanCAN #PurpleStride run on Saturday. This 5k run raises money to support the Pancreatic Cancer Action Network. The team, organized by Kirsten Bryant, raised $12,998 to support Pancreatic Cancer Research, coming in Second in overall fundraising!
World Pancreatic Cancer Day
The Der Lab has gone purple for the entire month of November for Pancreatic Cancer Awareness Month! Every day they wear purple they are raising money for the Pancreatic Cancer Action Network. Yesterday, November 17, was World Pancreatic Cancer Day and the lab spent the day showing their support for Pancreatic Cancer Research all day. See … Continue reading World Pancreatic Cancer Day
Photos from Purple Stride 2016
PurpleStride is the signature event of the Pancreatic Cancer Action Network. Each year, in communities across the country, tens of thousands of people participate in more than fifty-six PurpleStride events, including PurpleStride Raleigh-Durham. These events are critical in raising awareness and funds that advance research and support patients and loved ones with a promise of … Continue reading Photos from Purple Stride 2016
Purple is the New Black
Dr. Channing Der and the rest of the lab were featured in an article on the Carolina Scientific blog. The article highlights the science the lab is developing as well as the motivation behind the work for many members of the lab. To see the full article visit the Carolina Scientific website here: http://www.carolinascientific.org/blog/2016/3/6/karriuinq0hkifsfj50nznalaiqxup The Carolina … Continue reading Purple is the New Black
Meagan Ryan Awarded AACR-Woman in Cancer Research Scholar Award
Meagan Ryan, graduate student in the Der and Cox Labs and CCBTP trainee, has been selected to receive a Women in Cancer Research (WICR) Scholar Award. These awards are given annually to WICR members who are scientists-in-training and presenters of meritorious scientific papers at the AACR Annual Meeting. Meagan will present her poster on "Inhibition … Continue reading Meagan Ryan Awarded AACR-Woman in Cancer Research Scholar Award
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found a promising strategy that may limit the growth of pancreatic cancers in patients with a mutation in a gene called KRAS. More than 95 percent of pancreatic cancers have KRAS mutations, and there's strong evidence that blocking the gene's function could be a very … Continue reading Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
Der Lab 